Abortion Fight Isn’t Going Anywhere Anytime Soon
Recent court rulings over the so-called abortion pill are keeping the future of reproductive rights in the US a priority for all sides in the battle.
So much at stake.
Photographer: Anna Moneymaker/Getty Images North AmericaLast summer, the US Supreme Court overturned Roe v. Wade, the landmark decision that held abortion was a constitutionally protected right. Anti-abortion activists have been working overtime ever since to make abortion illegal nationwide, making medication abortion — the most popular method in the US for terminating a pregnancy — a primary target. They gained ground with help from the courts … sort of. As Bloomberg’s editorial board explains: “Federal judges in Texas and Washington issued two conflicting rulings on the abortion pill known as mifepristone. The first suspends the Food and Drug Administration’s approval of the drug nationwide; the second blocks the agency from restricting access to the very same drug.” On Friday, the Joe Biden administration took the case to the US Supreme Court, and Justice Samuel Alito put a five-day hold on the new restrictions. It’s a legal quagmire that has pro-choice advocates, abortion opponents and even Wall Street unsure of how to proceed. Bloomberg Opinion’s health and legal experts take a look at what the latest news means for the future reproductive health in the US.
Notes: To contact the author of this newsletter, email bsample1@bloomberg.net.